-+ 0.00%
-+ 0.00%
-+ 0.00%

Protagonist Therapeutics shareholders approve 2026 equity incentive plan at annual meeting

PUBT·06/18/2026 20:32:01
Listen to the news
Protagonist Therapeutics shareholders approve 2026 equity incentive plan at annual meeting
  • Protagonist Therapeutics held its annual meeting on June 17, 2026.
  • Stockholders adopted the 2026 Equity Incentive Plan, replacing the 2016 plan, authorizing up to 650,000 new shares for equity awards.
  • Stockholders also backed the slate of Class I director nominees, with terms running through the 2029 annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-075777), on June 18, 2026, and is solely responsible for the information contained therein.